Ellison Mark Jason Heath - Insider Non-Derivative Transactions at OPIANT PHARMACEUTICALS, INC. (OPNT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 2, 2023, Ellison Mark Jason Heath's relationship to OPIANT PHARMACEUTICALS, INC. (OPNT) is Officer (Chief Development Officer), and currently has 11,736 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other OPNT insiders.
Data Source: SEC.
Ellison Mark Jason Heath - Insider Non-Derivative Transactions of OPNT Common Stock
Ellison Mark Jason Heath - Insider Non-Derivative Transactions at OPNT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 3, 2023 | Disposition -- (Common Stock) | 9680 | 20 | 0 |
| Mar 3, 2023 | Disposition -- (Common Stock) | 2000 | 20 | 0 |
| Mar 3, 2023 | Disposition -- (Common Stock) | 11736 | 20 | 0 |
| Mar 3, 2023 | Acquisition -- (Common Stock) | 2000 | 0 | 2000 |
| Mar 3, 2023 | Disposition -- (Common Stock) | 7015 | 20 | 11736 |
| Jan 28, 2023 | Sell -- (Common Stock) | 610 | 20.26 | 18751 |
| Jan 10, 2023 | Sell -- (Common Stock) | 469 | 20.2 | 19361 |
| Jan 6, 2023 | Sell -- (Common Stock) | 1806 | 20.2 | 19830 |